REC: CardioClinics最新文献

{"title":"Continuidad asistencial entre cardiología y AP en pacientes con cardiopatía isquémica crónica: diseño del estudio CAPRICI","authors":"Sergio Cinza-Sanjurjo ,&nbsp;José Seijas-Amigo ,&nbsp;Beatriz Fontela-Sánchez ,&nbsp;Daniel Rey-Aldana ,&nbsp;Paloma Sempere-Serrano ,&nbsp;Pilar Mazón-Ramos ,&nbsp;Diego Gabriel Mosteiro-Miguéns ,&nbsp;Manuel Portela-Romero ,&nbsp;Nerea Sánchez-Varela ,&nbsp;Francisco Reyes-Santias ,&nbsp;M. Teresa Ferreiro-Serrano ,&nbsp;Mónica Barral-Carregal ,&nbsp;Andrea Grela-Beiroa ,&nbsp;Ana Suárez-Dios ,&nbsp;Isabel Rego-Lijó ,&nbsp;Jose Ramón González-Juanatey","doi":"10.1016/j.rccl.2024.07.004","DOIUrl":"10.1016/j.rccl.2024.07.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The management of cardiovascular risk factors (CVRF) should be conducted in Primary Care, which is particularly crucial for patients with prior cardiovascular disease. A semi-annual follow-up, aligned with the guidelines of clinical practice and coinciding with the administration of an injectable drug like inclisiran, could enhance healthcare efficiency. The CAPRICI study aims to analyze whether the implementation of a follow-up program, with semi-annual visits parallel to the administration of inclisiran in Primary Care, in patients with chronic ischemic heart disease, allows for optimized follow-up and improved control of CVRF.</div></div><div><h3>Methods</h3><div>The CAPRICI study is a randomized, controlled, prospective, multicenter trial involving 5 health centers in the Health Area of Santiago de Compostela and Barbanza: A Estrada, Concepción Arenal, Ribeira, Melide, and Milladoiro. The study will include patients with chronic coronary disease associated with other pathologies that increase cardiovascular risk, with elevated levels of low-density lipoprotein cholesterol (&gt; 100 mg/dl) despite conventional treatment with high-potency statins, with or without ezetimibe. The number of visits to healthcare services, as well as the control of CVRF and lifestyle habits, will be recorded.</div></div><div><h3>Conclusions</h3><div>The results of this study will contribute to improving the knowledge about the care of patients at very high cardiovascular risk, particularly in optimizing the number of visits and hospital referrals, as well as in the control of their CVRF.</div><div>Clinicaltrials.gov identifier: <span><span>NCT06421363</span><svg><path></path></svg></span></div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 8-16"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hipotensión en pacientes con síncope: prueba de basculación y monitorización de la presión arterial en la práctica clínica","authors":"Graciela Aurora Ruiz,&nbsp;Silvia Makhoul,&nbsp;Miguel Agustini,&nbsp;Vanina N. Gos Re,&nbsp;Sofía Maza,&nbsp;Julia Zarate,&nbsp;Paola Tombesi,&nbsp;Simon Salzberg","doi":"10.1016/j.rccl.2024.07.002","DOIUrl":"10.1016/j.rccl.2024.07.002","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Both ambulatory blood pressure monitoring (ABPM) and tilt-test (TT) can identify the hypotensive component that predisposes to syncope. The aim was to establish the prevalence of hypotension in ABPM and TT and to establish the concordance of the results between both methods.</div></div><div><h3>Methods</h3><div>Patients<!--> <!-->≥<!--> <!-->18 years with syncope in whom it was decided to perform a TT (45<!--> <!-->min at 75̊) were included. An ABPM was performed on different dates. The criteria of hypotension were: in TT, TT (+) or detection of systolic blood pressure<!--> <!-->≤<!--> <!-->100<!--> <!-->mmHg during the study, resulting from a drop respect to baseline systolic blood pressure; in ABPM, ≥<!--> <!-->2 falls<!--> <!-->≥<!--> <!-->20<!--> <!-->mmHg with respect to the previous one reaching systolic blood pressure<!--> <!-->≤<!--> <!-->100<!--> <!-->mmHg.</div></div><div><h3>Results</h3><div>A total of 61 patients were studied (62.5<!--> <!-->±<!--> <!-->16.8 years, 39 women [64%]). TT was positive in 41% of the patients. Additionally, during TT, hypotension was detected in another 18% of patients and hypotension by ABPM was observed in the 51%. Combining both methods, hypotension was detected in 79% of the population (48 patients). Both studies were concordant in 32 patients (52%) (Cohen kappa index: 0.04). Hypotension was identified in 28% of patients only by TT and in 20% only by ABPM.</div></div><div><h3>Conclusions</h3><div>Using a strategy combining TT and ABPM, hypotension was detected in three quarters of this population with syncope. Both methods proved to be complementary not only to develop a diagnostic suspicion but also to guide the therapeutic management of these patients.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 26-33"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving quality of life through a cardiac rehabilitation program: a 4-wave longitudinal study","authors":"M. José Ferreira-Díaz ,&nbsp;Ana Laguía ,&nbsp;Gabriela Topa","doi":"10.1016/j.rccl.2024.07.008","DOIUrl":"10.1016/j.rccl.2024.07.008","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Given the importance of cardiovascular disease, the leading cause of death in the world, and the fact that in Spain only 2–3% of the population can benefit from access to cardiac rehabilitation programs, the aim of this study is to consider the measurement of quality of life as a good indicator to determine the effectiveness of these programs. This longitudinal study evaluates the impact of a cardiac rehabilitation program on quality of life in a cohort of 181 patients at a Spanish hospital for 2 years.</div></div><div><h3>Methods</h3><div>Quality of life was assessed at four time points: on admission to the program, at discharge after 12 weeks, and at the 4- and 12-month revisions.</div></div><div><h3>Results</h3><div>The results show an increase in the perception of quality of life compared to the initial situation of the patients at the time of admission to the rehabilitation program, with positive results being observed in practically all the domains of the questionnaire, obtaining a higher score in the physical role domain.</div></div><div><h3>Conclusions</h3><div>This study shows that attendance at a cardiac rehabilitation program significantly improves self-perception of health, both physical and emotional.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 34-42"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Frecuencia y distribución geográfica de la prescripción de inhibidores de PCSK9 en Colombia entre 2019 y 2021","authors":"Tatiana Ramírez-Peña ,&nbsp;David Corredor-Orlandelli ,&nbsp;Daniel G. Fernández-Ávila ,&nbsp;Ángel Alberto García ,&nbsp;Óscar Muñoz-Velandia","doi":"10.1016/j.rccl.2024.06.003","DOIUrl":"10.1016/j.rccl.2024.06.003","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Proprotein convertase subtilisin/kexin type<!--> <!-->9 convertase inhibitors (iPCSK9) effectively reduce low-density lipoprotein cholesterol and have been shown to decrease cardiovascular morbidity and mortality in high-risk patients. However, their cost hinders their real accessibility. This study seeks to describe variables related to iPCSK9 prescription in Colombia.</div></div><div><h3>Methods</h3><div>Population-based analysis of iPCSK9 prescriptions in Colombia during the years 2019-2021, based on data from the government database <em>Sistema Integrado de Información de la Protección Social</em>. Information was extracted on sex, age groups, geographical area (department), health regime, ICD-10 code and the professional profile of the prescriber.</div></div><div><h3>Results</h3><div>There were 7431 prescriptions, 49.5% for alirocumab and 50.5% for evolocumab. Most patients were men &gt;<!--> <!-->50<!--> <!-->years old. The contributory regimen formulation was higher with a prescription rate ratio of 6.59 (95%CI, 6.147-7.073, <em>P</em> <!-->&lt;<!--> <!-->.01). The most populated areas had the highest prescribing, while six departments had no prescriptions. The most common indications were dyslipidaemia and ischaemic heart disease, with cardiologists and internists being the main prescribers.</div></div><div><h3>Conclusions</h3><div>Formulation of iPCSK9 was lower than expected. There were more formulations in men and people &gt;<!--> <!-->50<!--> <!-->years, data compatible with the higher incidence of cardiovascular disease in this population group. Regions with higher population density had more formulations and some areas, mainly rural, have no penetration. The marked differences in access between regions and regimens require further analysis to identify possible barriers to access.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 17-25"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141843591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Leiomiomatosis intravenosa con extensión intracardiaca y a la arteria pulmonar","authors":"Diana Isabel Katekaru-Tokeshi ,&nbsp;Félix Alonso Revilla-Manchego ,&nbsp;Luz Marilyn Vásquez-Salazar ,&nbsp;Moisés Jiménez-Santos","doi":"10.1016/j.rccl.2024.04.001","DOIUrl":"10.1016/j.rccl.2024.04.001","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 65-66"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cuatro años de SECoopera: ¿dónde estamos y qué hemos aprendido?","authors":"Marta Farrero ,&nbsp;Carolina Ortiz ,&nbsp;Sofía Cuenca","doi":"10.1016/j.rccl.2024.10.011","DOIUrl":"10.1016/j.rccl.2024.10.011","url":null,"abstract":"","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 4-7"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143170425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Válvula aórtica cuadricúspide: una revisión de la literatura","authors":"Danilo Weir-Restrepo ,&nbsp;María Antonia Mesa-Maya ,&nbsp;María Isabel Carvajal-Vélez ,&nbsp;Pedro Abad-Díaz ,&nbsp;Laura Duque-González","doi":"10.1016/j.rccl.2024.07.006","DOIUrl":"10.1016/j.rccl.2024.07.006","url":null,"abstract":"<div><div>The quadricuspid aortic valve (QAV) is a rare congenital heart defect characterized by the presence of 4 cusps in the aortic valve structure. It is frequently associated with other congenital heart defects. Patients are usually asymptomatic, but when this condition is associated with functional disorders such as aortic regurgitation or stenosis, clinical manifestations are evident. The final diagnosis is made using different cardiac imaging techniques such as echocardiography, cardiac tomography, and nuclear magnetic resonance.</div><div>The treatment of this condition depends on the functionality of the aortic valve, and accordingly will be the indication for surgical treatment. The prognosis is generally favorable and depends on the functional compromise of the valve.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"60 1","pages":"Pages 53-58"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contaminación ambiental y salud cardiovascular: enfoque integral y nuevas evidencias","authors":"Álvaro Lorente Ros ,&nbsp;Sonia Antoñana Ugalde ,&nbsp;Álvaro Izquierdo Bajo ,&nbsp;Luna Carrillo Alemán","doi":"10.1016/j.rccl.2024.09.002","DOIUrl":"10.1016/j.rccl.2024.09.002","url":null,"abstract":"<div><div>Environmental pollution profoundly affects cardiovascular health. Traditionally, recommendations on cardiovascular disease (CVD) prevention focus on modifiable behavioral and metabolic risk factors, but environmental pollution is emerging as a critical factor, causing up to 20% of cardiovascular mortality.</div><div>This review explores the impact of environmental factors on cardiovascular health, examining the evidence on contaminants such as microplastics, atmospheric and acoustic pollution, and exposure to heavy metals. It evaluates their influence on the development of cardiovascular disease and their association with increased mortality, as well as their interaction with traditional risk factors. Addressing environmental pollution is not only crucial for CVD prevention, but also an ethical imperative. A holistic approach that considers both traditional and environmental risk factors is crucial for designing effective public health strategies and addressing the ethical dimension inherent in the protection of human health and the environment.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 3-11"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143156640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abordaje de la hipertensión arterial pulmonar para el clínico: fisiopatología, diagnóstico y tratamiento","authors":"Manuel Giráldez Suárez ,&nbsp;Irene Martín de Miguel ,&nbsp;Mercedes Rivas-Lasarte ,&nbsp;María Álvarez Barredo","doi":"10.1016/j.rccl.2024.10.001","DOIUrl":"10.1016/j.rccl.2024.10.001","url":null,"abstract":"<div><div>Pulmonary arterial hypertension (PAH) is a rare and serious pathology in which abnormal pulmonary vascular remodeling occurs causing increased pulmonary vascular resistance, pulmonary pressures and right ventricular afterload, leading to right heart failure due to right ventricular failure, which is the main cause of death. Advances in the understanding of the pathophysiological mechanisms of the disease have allowed the development of new molecular compounds aimed at partially reversing the alterations in the pulmonary vasculature, providing additional mechanisms of action and therapeutic targets to the classic pulmonary vasodilator drugs. This work covers a review of the pathophysiological mechanisms, the diagnostic process of PAH, considering how to integrate the different clinical elements and diagnostic tests for an early and correct diagnosis, and presents the available and developing molecular compounds with an analysis of the potential role of the latter in current therapeutic algorithms.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 24-40"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143157101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Controversias en la revascularización y el estudio de viabilidad miocárdica en el síndrome coronario crónico","authors":"Luis Carlos Maestre-Luque ,&nbsp;Rafael González-Manzanares ,&nbsp;Clara Fernández-Cordón ,&nbsp;Felipe Díez-Delhoyo","doi":"10.1016/j.rccl.2024.09.003","DOIUrl":"10.1016/j.rccl.2024.09.003","url":null,"abstract":"<div><div>The broad spectrum of patients with chronic coronary syndrome and the controversies in diagnosis and treatment pose a major challenge in clinical decision making. Concerning the diagnosis, the utility of myocardial viability study has been questioned by recent clinical trials. Regarding the therapeutic approach, in patients with simple coronary disease, percutaneous revascularization has proved its utility in anginal symptoms relieve, but the evidence regarding a prognostic benefit is contradictory. In complex coronary disease, coronary artery bypass grafting surgery has reported better results than percutaneous intervention. Besides, surgical revascularization has demonstrated a reduction in cardiovascular events over medical treatment in patients with ischemic left ventricular dysfunction. In this review we critically analyse the current evidence on viability study and myocardial revascularization in patients with chronic coronary syndrome.</div></div>","PeriodicalId":36870,"journal":{"name":"REC: CardioClinics","volume":"59 ","pages":"Pages 12-23"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143157102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}